Tofacitinib Versus Methotrexate in Treating Mucocutaneous and Musculoskeletal Lesions of Systemic Lupus Erythematosus: Real‐World Results From the CSTAR Cohort XXXII
Sign Up to like & getrecommendations! Published in 2025 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.70283
Abstract: This study aimed to evaluate and compare the efficacy and safety of tofacitinib versus methotrexate in the management of systemic lupus erythematosus (SLE) within a real‐world cohort, with a particular focus on mucocutaneous and musculoskeletal… read more here.
Keywords: tofacitinib versus; real world; systemic lupus; mucocutaneous musculoskeletal ... See more keywords